NEW YORK (GenomeWeb News) — TechniKrom will supply its large-scale oligosynthesis equipment to South Korea-based Samchully Pharm, which is currently expanding its manufacturing facility in that country, the companies said today.
 
Under the agreement, TechniKrom, based in Evanston, Ill., will provide Samchully with its engineering, fabrication, and qualification services to supply 100-mmol scale cGMP oligosynthesis and HPLC equipment.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.